
Jennifer Kelschenbach, PhD
About Me
My Ph.D. training in Pharmacology led me to join the laboratory of Dr. Sabita Roy, in which I pursued thesis research that involved the study of morphine withdrawal on T helper cell functioning. This training provided me with a solid background in murine immunology and drugs of abuse research. Through my thesis research I also gained necessary laboratory skills and techniques that prepared and continue to serve me well in my current and future research endeavors. Upon completion of my Ph.D., I joined the lab of Dr. David J. Volsky in the Molecular Virology Division at St. Luke’s-Roosevelt Hospital Center to gain experience in HIV biology systemically. This training led to the current position I hold within the Icahn School of Medicine at Mount Sinai and my growing interests on the effects that HIV has on neurocognitive functioning. To that end, I was instrumental in developing and establishing procedures that would allow for viral delivery to the brain as well as establishing behavioral paradigms that would allow for the assessment of neurocognitive decline in our mouse model of HIV. My research goals have come full circle as I have recently applied this training to optimizing the study of HIV replication in the brain and periphery, with the goal of investigating how morphine may influence virus entry into the central nervous system and subsequently effect behavioral outcomes.
Language
English
Position
ADJUNCT ASSISTANT PROFESSOR | Medicine, Infectious Diseases
Education
BS, State University of New York at Binghamton
PhD, University of Minnesota
Publications
Selected Publications
- EcoHIV Infection Promotes Atherosclerosis Progression in LDLR-Deficient Mice. Ivan Pinos, Amparo Blanco, Jennifer Kelschenbach, Mike Veenstra, Eva Hu, Hongxia He, Joan W. Berman, David J. Volsky, Jaume Amengual. Arteriosclerosis, Thrombosis, and Vascular Biology
- The single-cell opioid responses in the context of HIV (SCORCH) consortium. Seth A. Ament, Rianne R. Campbell, Mary Kay Lobo, Joseph P. Receveur, Kriti Agrawal, Alejandra Borjabad, Siddappa N. Byrareddy, Linda Chang, Declan Clarke, Prashant Emani, Dana Gabuzda, Kyle J. Gaulton, Michelle Giglio, Federico M. Giorgi, Busra Gok, Chittibabu Guda, Eran Hadas, Brian R. Herb, Wen Hu, Anita Huttner, Mohammad R. Ishmam, Michelle M. Jacobs, Jennifer Kelschenbach, Dong Wook Kim, Cheyu Lee, Shuhui Liu, Xiaokun Liu, Bertha K. Madras, Anup A. Mahurkar, Deborah C. Mash, Eran A. Mukamel, Meng Niu, Richard M. O’Connor, Chelsea M. Pagan, Alina P.S. Pang, Piya Pillai, Vez Repunte-Canonigo, W. Brad Ruzicka, Jay Stanley, Timothy Tickle, Shang Yi A. Tsai, Allen Wang, Lauren Wills, Alyssa M. Wilson, Susan N. Wright, Siwei Xu, Junchen Yang, Maryam Zand, Le Zhang, Jing Zhang, Schahram Akbarian, Shilpa Buch, Christine S. Cheng, Michael J. Corley, Howard S. Fox, Mark Gerstein, Suryaram Gummuluru, Myriam Heiman, Ya Chi Ho, Manolis Kellis, Paul J. Kenny, Yuval Kluger, Teresa A. Milner, David J. Moore, Susan Morgello, Lishomwa C. Ndhlovu, Tariq M. Rana, Pietro Paolo Sanna, John S. Satterlee, Nenad Sestan, Stephen A. Spector, Serena Spudich, Hagen U. Tilgner, David J. Volsky, Owen R. White, Dionne W. Williams, Hongkui Zeng. Molecular Psychiatry
- CCL2 is required for initiation but not persistence of HIV infection mediated neurocognitive disease in mice. Boe Hyun Kim, Eran Hadas, Jennifer Kelschenbach, Wei Chao, Chao Jiang Gu, Mary Jane Potash, David J. Volsky. Scientific Reports